S. Sumodhee

Centre Antoine Lacassagne

Papers

1

Total Citations

3

H-Index

1

About

S. Sumodhee is a clinical researcher whose work centers on the intersection of radiation oncology and surgical precision, particularly in the treatment of early-stage breast cancer. Their most notable contribution is the phase 2 trial "Robotic Stereotactic Boost in Early Breast Cancer," which explored the use of robotic stereotactic radiosurgery to deliver a targeted radiation boost following breast-conserving surgery. This study, published in 2018, has garnered 3 citations and represents a pioneering effort to refine adjuvant therapy, aiming to reduce local recurrence while minimizing damage to healthy tissue. Sumodhee’s research addresses a critical gap in oncologic care: optimizing dose delivery in the post-lumpectomy setting. By integrating robotic precision with stereotactic techniques, they have helped advance the paradigm of personalized, minimally invasive cancer treatment. Their work is particularly relevant for researchers and clinicians interested in the evolving role of technology in radiotherapy, offering a glimpse into how robotic systems can enhance the therapeutic ratio. Though early in its citation impact, this trial lays groundwork for future studies on hypofractionated regimens and patient-specific planning. Sumodhee’s contributions underscore a commitment to translating engineering innovation into tangible clinical benefits for breast cancer patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Stereotactic Boost in Early Breast Cancer, a Phase 2 Trial
3 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Centre Antoine Lacassagne

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago